CD79A and systemic lupus erythematosus: In humans, PRL increases the production of IgA, IgM, and IgG in the PBMCs of healthy individuals and, to a greater extent, in patients with SLE, as well as the synthesis of anti-dsDNA IgG in vitro (127, 128).